Univariable and multivariable analyzes for loss of LTNP and HIV controller status.

<p>Univariable and multivariable analyzes for loss of LTNP and HIV controller status.</p

Characteristics of LTNP and HIC patients identified in 2005 who maintained or lost their status during follow-up.

<p>Characteristics of LTNP and HIC patients identified in 2005 who maintained or lost their status during follow-up.</p

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4 - Fig 1

<p><b>Cumulative incidence of loss of LTNP (panel A) and HIV controller (panel B) status, treatment initiation and non AIDS deaths since 2005. A:</b> Long-term non-progressors (n = 171). <b>B:</b> HIV controllers (n = 72).</p

Additional file 3: Tables S2. of Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination

Multivariate parameter estimates for covariate association with the risk of anal cancer in HIV-infected persons: comparison of weighted Cox MSM and standard time dependent Cox models. (DOCX 22 kb

Database Patients’ subjective assessment of the duration of cataract surgery

Database Patients’ subjective assessment of the duration of cataract surger

First-line cART regimens started during follow-up, N = 8543.

<p>Data are counts (proportions).</p><p>^a Mainly PI/r + II or PI/r + NNRTI or 2 PIs/r.</p><p>^b Mainly PI/r monotherapy or 1 II + 1 PI/r or 1 PI/r + 1 NNRTI.</p><p>Abbreviations: FRA, French natives; SSA, sub-Saharan Africa; NFW, non-French West Indies; OTH, Other regions of the world; MSM, Men who have sex with men; cART, combination antiretroviral therapy; NRTI, Nucleoside Reverse Transcriptase Inhibitor; PI/r, ritonavir-boosted protease inhibitor; NNRTI, Non-nucleoside Reverse Transcriptase Inhibitor; II, Integrase inhibitor; PI, Protease Inhibitor.</p><p>First-line cART regimens started during follow-up, N = 8543.</p

Individuals selection.

<p>Abbreviations: ADE, AIDS-defining event; cART, combination antiretroviral therapy; NRTI, Nucleoside Reverse Transcriptase Inhibitor.</p

Kaplan-Meier survival estimates of first-line cART initiation by geographic origin and CD4 cell counts [/μL] at enrolment.

<p>Abbreviations: cART, combination antiretroviral therapy; FRA, French natives; SSA, sub-Saharan Africa; NFW, non-French West Indies; OTH, Other regions of the world.</p

Univariate and multivariate Hazard Ratios (HRs) for cART initiation according to geographic origin, gender and HIV transmission group in baseline CD4 cell count strata (Cox model).

<p>* HR adjusted for age at enrolment, enrolment period, region of care, pVL at enrolment, and hepatitis B antigen and hepatitis C antibody status; Abbreviations: cART, Combination antiretroviral therapy; FRA, French natives; SSA, sub-Saharan Africa; NFW, non-French West Indies; OTH, Other regions of the world; MSM, Men who have sex with men.</p

Frequency distribution of patients grouped by five-year mortality risk, overall and by age-group.

<p>Frequency distribution of patients grouped by five-year mortality risk, overall and by age-group.</p